NASDAQ:RCKT

Rocket Pharmaceuticals Stock Forecast

etoro logo Buy RCKT
*Your capital is at risk
$3.25
+0.0100 (+0.309%)
At Close: Jun 26, 2026
AI Analysis AI Analysis of RCKT AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add RCKT to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Volatile ride for Rocket Pharmaceuticals Inc stock price on Friday moving between $3.08 and $3.40
(Updated on Jun 26, 2026)

Buy or Hold candidate since Jun 17, 2026 Gain 2.85%

The Rocket Pharmaceuticals Inc stock price gained 0.309% on the last trading day (Friday, 26th Jun 2026), rising from $3.24 to $3.25. During the last trading day the stock fluctuated 10.39% from a day low at $3.08 to a day high of $3.40. The price has risen in 7 of the last 10 days and is up by 22.18% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 6 million more shares were traded than the day before. In total, 8 million shares were bought and sold for approximately $24.94 million.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $3.43 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -20.24% during the next 3 months and, with a 90% probability hold a price between $1.95 and $2.73 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

RCKT Signals & Forecast

The Rocket Pharmaceuticals Inc stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $3.32. On a fall, the stock will find some support from the long-term average at approximately $3.10. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, June 23, 2026, and so far it has fallen -6.34%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Rocket Pharmaceuticals Inc stock

On the downside, the stock finds support just below today's level from accumulated volume at $3.07 and $2.92. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Rocket Pharmaceuticals Inc finds support just below today's level at $3.07. If this is broken, then the next support from accumulated volume will be at $2.92 and $2.75.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.320 between high and low, or 10.39%. For the last week, the stock has had daily average volatility of 7.03%.

Our recommended stop-loss: $3.07 (-5.64%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 3 days ago.)

Trading Expectations (RCKT) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Rocket Pharmaceuticals Inc to open at $3.24, and during the day (based on 14 day Average True Range), to move between $3.15 and $3.35, which gives a possible trading interval of +/-$0.208 (+/-6.60%) up or down from last closing price. If Rocket Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 6.60% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $3.35 (3.08%) than the support at $3.07 (5.54%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Rocket Pharmaceuticals Inc stock A Buy?

Rocket Pharmaceuticals Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: -0.905 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 29, 2026 - $3.24 ( 0.205%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

RCKT Performance

Trading levels for RCKT

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 3.56 9.64%
R2 3.44 5.88%
R1 3.37 3.56%
Price 3.25
S1 3.12 -3.97%
S2 3.05 -6.29%
S3 2.92 -10.05%

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.77 16.00%
R2 3.45 6.00%
R1 3.35 3.08%
Price 3.25
S1 3.07 -5.54%
S2 2.92 -10.15%
S3 2.75 -15.38%

FAQ

What is the symbol for Rocket Pharmaceuticals Inc Stock and on which exchange is it traded?
The symbol for Rocket Pharmaceuticals Inc is RCKT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Rocket Pharmaceuticals Inc Stock?
Rocket Pharmaceuticals Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

How to buy Rocket Pharmaceuticals Inc Stock?
Rocket Pharmaceuticals Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Rocket Pharmaceuticals Inc Stock.

What's the current price of Rocket Pharmaceuticals Inc Stock?
As of the end of day on the Jun 26, 2026, the price of an Rocket Pharmaceuticals Inc (RCKT) share was $3.25.

What is the 52-week high and low for Rocket Pharmaceuticals Inc Stock?
The 52-week high for Rocket Pharmaceuticals Inc Stock is $5.45 and the 52-week low is $2.40.

What is the market capitalization of Rocket Pharmaceuticals Inc Stock?
As of the Jun 26, 2026, the market capitalization of Rocket Pharmaceuticals Inc is 354.879M.

When is the next earnings date for Rocket Pharmaceuticals Inc?
The upcoming earnings date for Rocket Pharmaceuticals Inc is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT ROCKET PHARMACEUTICALS INC
Rocket Pharmaceuticals
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder ...
GOLDEN STAR
Ticker Change Signal Date
NMRK
$15.02
1.66% Jun 24
X
XMAX
$8.34
5.40% Jun 24
JLL
$299.78
5.10% Jun 24
NESR
$25.07
12.64% Jun 23
TTEK
$28.04
4.35% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE